Investigating how cyclin G1 and CDK5 affect chronic kidney disease.
The role of cyclin G1 and CDK5 in chronic kidney disease.
This study is looking at how certain proteins affect kidney cells' ability to heal after injury, which could help us find better treatments for people with chronic kidney disease.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Vanderbilt University Medical Center NIH-funded |
| Lab location | 1 site (Nashville, United States) |
| Project ID | NIH-11138674 on NIH RePORTER |
What this research studies
This research focuses on understanding the mechanisms behind chronic kidney disease (CKD), which affects a significant portion of the population and leads to severe kidney damage. The study examines how certain proteins, cyclin G1 and CDK5, influence kidney cells' ability to recover from injury and contribute to fibrosis, a condition that worsens kidney function. By using specific genetic models, the researchers aim to uncover why some kidney cells fail to heal while others can regenerate, potentially leading to new therapeutic strategies for CKD.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with chronic kidney disease, particularly those experiencing progressive fibrosis.
Not a fit: Patients with acute kidney injury or those without chronic kidney disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that prevent the progression of chronic kidney disease and improve kidney function in affected patients.
How similar studies have performed: Previous research has shown promising results in understanding cellular mechanisms in kidney disease, suggesting that this approach could yield valuable insights.
Where this research is happening
Nashville, United States
- Vanderbilt University Medical Center — Nashville, United States (Active)
Researchers
- Principal investigator: Brooks, Craig Robert — Vanderbilt University Medical Center
- Study coordinator: Brooks, Craig Robert
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.